Alopecia Market

Alopecia Market Size By Disease Type (Cicatricial Alopecia, Alopecia Areata, Alopecia Totalis, Traction Alopecia, Androgenetic Alopecia, Alopecia Universalis, and Others), By Treatment (Devices and Pharmaceutical), By End-User (Dermatology Clinics and Homecare Settings), Regions, Global Industry Analysis, Share, Growth, and Trends. Forecast 2023 to 2031

Base Year: 2022 Historical Data: 2019-21
  • Report ID: TBI-13251
  • Published Date: Jan, 2023
  • Pages: 236
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The global alopecia market is expected to reach USD 15.3 billion by 2031, at a CAGR of 8.5% during the forecast period 2023 to 2031. Asia Pacific is expected to grow the fastest during the forecast period. 

Market Overview:

Spot baldness is another name for alopecia areata. It is a medical disorder in which all or partial body parts lose their hair. It frequently causes a few bald spots on people's scalps. Typically, a spot is the size of a penny. Often, the entire head or body's hair may fall out permanently. A family history of the same illness is one risk factor for alopecia areata. The mechanism involves the body's inability to identify its cells due to hair follicle loss. There is currently no known treatment for the condition. However, various drugs are being explored for regrowth, such as cortisone injections, sunscreen to protect the affected area from the sun and cold, and glasses if eyelashes have been damaged or are absent. After some time, the 'M'-shaped hairline foam feature is frequently on the way to partial or total baldness. It is a different condition for girls than it is for guys. Women have thinning hair all over the head, frequently progressing to complete baldness. The increasing prevalence of alopecia is primarily attributed to changing lifestyle habits such as excessive drinking and tobacco use and increased stress levels among the populace. Although the disease's epidemiology is unknown, the hereditary component is thought to be one of its causes and is connected to numerous cases of alopecia. The market for alopecia products is also expected to develop as a result of rising disposable income and a growing emphasis on aesthetics. Alopecia treatment demand is significantly increased by ageing and abnormalities. In terms of illness vulnerability, gender also has a significant impact. According to the American Hair Loss Association, androgenic alopecia is the cause of around 95% of hair loss in men, and consumer awareness is promoting market expansion.

Alopecia Market Size

Get an overview of this study by requesting a free sample

Recent Development
  • On February 25, 2021, The long-term care (LTC) division website for Sun Pharmaceutical, www.sunltc.com, went live in the U.S.
  • On May 28, 2021, Sun Pharmaceutical Industries altered the distribution services agreement and bought trademarks and patent rights for dapagliflozin and its combinations from AstraZeneca AB.
  • On May 10, 2021, a royalty-free, a non-exclusive voluntary licencing deal with Eli Lilly and Company ("Lilly") was made public to increase India's access to baricitinib. Sun Pharma will produce and market the medication in India.

Market Dynamics:

Drivers

Rise in Hair Loss - The market for alopecia areata is expected to rise as hair loss becomes more common. According to the American Academy of Dermatology Association (AAD), around 30 million women and 50 million men in the U.S. were estimated to have alopecia in 2018. Approximately 60% of people experience hair thinning, with pattern hair loss being the most prevalent kind of hair loss in both men and women, according to the Journal of Clinical and Diagnostic Research (JCDR). Additionally, regardless of gender, 2% of the general population is susceptible to developing alopecia areata in their lifetime.

Restraints:

High Cost- The high cost of the treatment will impede the market's rate of expansion. The demand for alopecia areata will be challenged by limited primary care services and a lack of healthcare infrastructure in emerging nations. Additionally, during the forecast period, rigorous regulatory rules and a lack of public awareness would serve as restraints and further restrict the market's growth pace.

Opportunities:

The Rise in Research & Development -An increase in the quantity of R&D activities is another factor driving the market's expansion. This will present advantageous chances for the demand for alopecia areata to expand. Additionally, increasing drug releases and approvals will speed up the market's development. Alopecia areata market growth will also benefit from increased investments in developing cutting-edge technologies and an increase in the number of emerging markets during the forecast period.

Challenges:

Reimbursement- Reimbursement continues to be a significant obstacle in this industry. Insurance policies only cover some treatment techniques for hair loss since they are seen as aesthetic procedures rather than medically necessary ones. In general, out-of-pocket expenses for treating alopecia include copays for prescription medications, frequent doctor visits, and co-insurance for treatment methods. The market's expansion may also need to be improved by the growing use of alternatives like traditional treatments like Ayurvedic, Chinese, and homemade pharmaceuticals.

Regional segmentation analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the largest market for the global alopecia market, with a 40% share of the market revenue in 2023.

North America currently dominates the alopecia market with a 40% market revenue share in 2023. High disease prevalence, increased consumer awareness, proactive government action, technological breakthroughs, and improvements to the healthcare system's infrastructure all contribute to the growth. A significant driver of the market's expansion is the existence of essential players in this area. Additionally, the region sees more people receiving laser-based treatments to treat alopecia. The National Alopecia Areata Foundation (NAAF), the Canadian Alopecia Areata Foundation, and other government and non-profit organisations that establish recommendations and raise public awareness are likely to have a favourable effect on the market.

Asia Pacific is expected to witness the fastest growth during the forecast period. Due to more significant disposable income, more customer knowledge, and increased penetration of alopecia products. Additionally, it is anticipated that enhancing the healthcare regulatory environment in emerging nations will draw in foreign investors and open up new business opportunities. For instance, China's regulatory body, the China Food and Drug Administration, authorized the iGrow laser system by Apira Science in 2016, making it the country's first-ever laser-based hair growth technology.

North America Region Alopecia Market Share in 2023 - 40%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

Disease Type Analysis:

The disease type segment is divided into cicatricial alopecia, alopecia areata, alopecia totalis, traction alopecia, androgenetic alopecia, alopecia universalis, and others. The alopecia areata segment dominated the market, with a market share of around 33% in 2023, because of the high disease prevalence and rising patient consumer awareness. According to the National Alopecia Areata Foundation, approximately 6.8 million of the about 147.0 million persons affected by A.A. live in the United States alone. Due to an increase in the discovery of novel therapies and supportive initiatives in the approval process, the market is predicted to grow significantly over the forecast period. For instance, the U.S. FDA granted baricitinib's Breakthrough Therapy Designation for the treatment of A.A. in March 2020 to Incyte Corporation and Eli Lilly and Company. The designation as a "breakthrough therapy" will speed up the approval process.

Treatment Analysis:

The treatment segment is divided into devices and pharmaceuticals. Over the forecast period, the pharmaceuticals segment will grow at the fastest CAGR of 8.6%. The low cost of pharmaceutical items and the high consumption of prescription and over-the-counter medications primarily drive the segment. The most popular medicines used to treat any form of alopecia are finasteride and minoxidil. The only drugs in the United States that are licenced for the treatment of both Male Pattern Hair Loss (MPHL) and Female Pattern Hair Loss (FPHL) are finasteride and minoxidil (MPHL). Major pharmaceutical firms are also actively involved in discovering novel medications to treat alopecia, which is predicted to drive the industry throughout the projection period. Examples include Lilly, Pfizer Inc., and Concert Pharmaceuticals.

End-User Analysis:

The end-user segment is divided into dermatology clinics and homecare settings. The dermatology clinics segment dominated, with a market share of around 57% in 2023. The utilization of modern treatment techniques, including laser technology, a robust product pipeline, and increased consumer awareness of the usage of prescription drugs are the key drivers of the segment's continuous growth. The consulting dermatologist is frequently regarded as the best alternative for treating alopecia due to their capacity to offer suitable personalized medications or therapy that produce positive outcomes.

List of Key Market Players:
  • F. Hoffmann-La Roche Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • GlaxoSmithKline plc
  • Sanofi
  • Pfizer Inc.
  • Bayer AG
  • Novartis AG
  • Merck & Co., Inc.
  • Eli Lilly and Company
  • AstraZeneca
  • Allergan
  • AbbVie Inc.
  • Johnson & Johnson Private Limited

Report Description: 

Attribute Description
Market Size Revenue (USD Billion)
Market size value in 2023 USD 8 billion
Market size value in 2031 USD 15.3 billion
CAGR (2023 to 2031) 8.5%
Historical data 2019-2021
Base Year 2022
Forecast 2023-2031
Regional Segments North America, Asia Pacific, Europe, Latin America, Middle East and Africa
Segments Disease Type, Treatment, End-User

Frequesntly Asked Questions

As per The Brainy Insights, the size of the alopecia market was valued at USD 8 billion in 2023 to USD 15.3 billion by 2031.

The global alopecia market is growing at a CAGR of 8.5% during the forecast period 2023-2031.

North America emerged as the largest market for Alopecia.

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis By Disease Type
          4.3.2. Market Attractiveness Analysis By Treatment
          4.3.3. Market Attractiveness Analysis By End-User
          4.3.4. Market Attractiveness Analysis By Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. Rise in Hair Loss
    5.3. Restraints
          5.3.1. High Cost
    5.4. Opportunities
          5.4.1. The rise in Research & Development
    5.5. Challenges
          5.5.1. Reimbursement

6. Global Alopecia Market Analysis and Forecast, By Disease Type
    6.1. Segment Overview
    6.2. Cicatricial Alopecia
    6.3. Alopecia Areata
    6.4. Alopecia Totalis
    6.5. Traction Alopecia
    6.6. Androgenetic Alopecia
    6.7. Alopecia Universalis
    6.8. Others

7. Global Alopecia Market Analysis and Forecast, By Treatment
    7.1. Segment Overview
    7.2. Devices
    7.3. Pharmaceutical

8. Global Alopecia Market Analysis and Forecast, By Treatment
    8.1. Segment Overview
    8.2. Dermatology Clinics
    8.3. Homecare Settings

9. Global Alopecia Market Analysis and Forecast, By Regional Analysis
    9.1. Segment Overview
    9.2. North America
          9.2.1. U.S.
          9.2.2. Canada
          9.2.3. Mexico
    9.3. Europe
          9.3.1. Germany
          9.3.2. France
          9.3.3. U.K.
          9.3.4. Italy
          9.3.5. Spain
    9.4. Asia-Pacific
          9.4.1. Japan
          9.4.2. China
          9.4.3. India
    9.5. South America
          9.5.1. Brazil
    9.6. Middle East and Africa
          9.6.1. UAE
          9.6.2. South Africa

10. Global Alopecia Market-Competitive Landscape
    10.1. Overview
    10.2. Market Share of Key Players in Global Alopecia Market
          10.2.1. Global Company Market Share
          10.2.2. North America Company Market Share
          10.2.3. Europe Company Market Share
          10.2.4. APAC Company Market Share
    10.3. Competitive Situations and Trends
          10.3.1. product Launches and Developments
          10.3.2. Partnerships, Collaborations, and Agreements
          10.3.3. Mergers & Acquisitions
          10.3.4. Expansions

11. Company Profiles
    11.1. F. Hoffmann-La Roche Ltd.
          11.1.1. Business Overview
          11.1.2. Company Snapshot
          11.1.3. Company Market Share Analysis
          11.1.4. Company product Portfolio
          11.1.5. Recent Developments
          11.1.6. SWOT Analysis
    11.2. Teva Pharmaceutical Industries Ltd.
          11.2.1. Business Overview
          11.2.2. Company Snapshot
          11.2.3. Company Market Share Analysis
          11.2.4. Company product Portfolio
          11.2.5. Recent Developments
          11.2.6. SWOT Analysis
    11.3. Mylan N.V.
          11.3.1. Business Overview
          11.3.2. Company Snapshot
          11.3.3. Company Market Share Analysis
          11.3.4. Company product Portfolio
          11.3.5. Recent Developments
          11.3.6. SWOT Analysis
    11.4. GlaxoSmithKline plc
          11.4.1. Business Overview
          11.4.2. Company Snapshot
          11.4.3. Company Market Share Analysis
          11.4.4. Company Product Portfolio
          11.4.5. Recent Developments
          11.4.6. SWOT Analysis
    11.5. Sanofi
          11.5.1. Business Overview
          11.5.2. Company Snapshot
          11.5.3. Company Market Share Analysis
          11.5.4. Company product Portfolio
          11.5.5. Recent Developments
          11.5.6. SWOT Analysis
    11.6. Pfizer Inc.
          11.6.1. Business Overview
          11.6.2. Company Snapshot
          11.6.3. Company Market Share Analysis
          11.6.4. Company product Portfolio
          11.6.5. Recent Developments
          11.6.6. SWOT Analysis
    11.7. Bayer AG
          11.7.1. Business Overview
          11.7.2. Company Snapshot
          11.7.3. Company Market Share Analysis
          11.7.4. Company product Portfolio
          11.7.5. Recent Developments
          11.7.6. SWOT Analysis
    11.8. Novartis AG
          11.8.1. Business Overview
          11.8.2. Company Snapshot
          11.8.3. Company Market Share Analysis
          11.8.4. Company product Portfolio
          11.8.5. Recent Developments
          11.8.6. SWOT Analysis
    11.9. Merck & Co., Inc.
          11.9.1. Business Overview
          11.9.2. Company Snapshot
          11.9.3. Company Market Share Analysis
          11.9.4. Company product Portfolio
          11.9.5. Recent Developments
          11.9.6. SWOT Analysis
    11.10. Eli Lilly and Company
          11.10.1. Business Overview
          11.10.2. Company Snapshot
          11.10.3. Company Market Share Analysis
          11.10.4. Company product Portfolio
          11.10.5. Recent Developments
          11.10.6. SWOT Analysis
 

List of Table

1. Global Alopecia Market, By Disease Type, 2019-2031 (USD Billion)

2. Global Cicatricial Alopecia, Alopecia Market, By Region, 2019-2031 (USD Billion) 

3. Global Alopecia Areata, Alopecia Market, By Region, 2019-2031 (USD Billion)

4. Global Alopecia Totalis, Alopecia Market, By Region, 2019-2031 (USD Billion) 

5. Global Traction Alopecia, Alopecia Market, By Region, 2019-2031 (USD Billion) 

6. Global Androgenetic Alopecia, Alopecia Market, By Region, 2019-2031 (USD Billion) 

7. Global Alopecia Universalis, Alopecia Market, By Region, 2019-2031 (USD Billion)

8. Global Others, Alopecia Market, By Region, 2019-2031 (USD Billion)  

9. Global Alopecia Market, By Treatment, 2019-2031 (USD Billion)

10. Global Devices, Alopecia Market, By Region, 2019-2031 (USD Billion)

11. Global Pharmaceutical, Alopecia Market, By Region, 2019-2031 (USD Billion)

12. Global Alopecia Market, By End-User, 2019-2031 (USD Billion)

13. Global Dermatology Clinics, Alopecia Market, By Region, 2019-2031 (USD Billion)

14. Global Homecare Settings, Alopecia Market, By Region, 2019-2031 (USD Billion)

15. North America Alopecia Market, By Disease Type, 2019-2031 (USD Billion)

16. North America Alopecia Market, By Treatment, 2019-2031 (USD Billion)

17. North America Alopecia Market, By End-User, 2019-2031 (USD Billion)

18. U.S. Alopecia Market, By Disease Type, 2019-2031 (USD Billion)

19. U.S. Alopecia Market, By Treatment, 2019-2031 (USD Billion)

20. U.S. Alopecia Market, By End-User, 2019-2031 (USD Billion)

21. Canada Alopecia Market, By Disease Type, 2019-2031 (USD Billion)

22. Canada Alopecia Market, By Treatment, 2019-2031 (USD Billion)

23. Canada Alopecia Market, By End-User, 2019-2031 (USD Billion)

24. Mexico Alopecia Market, By Disease Type, 2019-2031 (USD Billion)

25. Mexico Alopecia Market, By Treatment, 2019-2031 (USD Billion)

26. Mexico Alopecia Market, By End-User, 2019-2031 (USD Billion)

27. Europe Alopecia Market, By Disease Type, 2019-2031 (USD Billion)

28. Europe Alopecia Market, By Treatment, 2019-2031 (USD Billion)

29. Europe Alopecia Market, By End-User, 2019-2031 (USD Billion)

30. Germany Alopecia Market, By Disease Type, 2019-2031 (USD Billion)

31. Germany Alopecia Market, By Treatment, 2019-2031 (USD Billion)

32. Germany Alopecia Market, By End-User, 2019-2031 (USD Billion)

33. France Alopecia Market, By Disease Type, 2019-2031 (USD Billion)

34. France Alopecia Market, By Treatment, 2019-2031 (USD Billion)

35. France Alopecia Market, By End-User, 2019-2031 (USD Billion)

36. U.K. Alopecia Market, By Disease Type, 2019-2031 (USD Billion)

37. U.K. Alopecia Market, By Treatment, 2019-2031 (USD Billion)

38. U.K. Alopecia Market, By End-User, 2019-2031 (USD Billion)

39. Italy Alopecia Market, By Disease Type, 2019-2031 (USD Billion)

40. Italy Alopecia Market, By Treatment, 2019-2031 (USD Billion)

41. Italy Alopecia Market, By End-User, 2019-2031 (USD Billion)

42. Spain Alopecia Market, By Disease Type, 2019-2031 (USD Billion)

43. Spain Alopecia Market, By Treatment, 2019-2031 (USD Billion)

44. Spain Alopecia Market, By End-User, 2019-2031 (USD Billion)

45. Asia Pacific Alopecia Market, By Disease Type, 2019-2031 (USD Billion)

46. Asia Pacific Alopecia Market, By Treatment, 2019-2031 (USD Billion)

47. Asia Pacific Alopecia Market, By End-User, 2019-2031 (USD Billion)

48. Japan Alopecia Market, By Disease Type, 2019-2031 (USD Billion)

49. Japan Alopecia Market, By Treatment, 2019-2031 (USD Billion)

50. Japan Alopecia Market, By End-User, 2019-2031 (USD Billion)

51. China Alopecia Market, By Disease Type, 2019-2031 (USD Billion)

52. China Alopecia Market, By Treatment, 2019-2031 (USD Billion)

53. China Alopecia Market, By End-User, 2019-2031 (USD Billion)

54. India Alopecia Market, By Disease Type, 2019-2031 (USD Billion)

55. India Alopecia Market, By Treatment, 2019-2031 (USD Billion)

56. India Alopecia Market, By End-User, 2019-2031 (USD Billion)

57. South America Alopecia Market, By Disease Type, 2019-2031 (USD Billion)

58. South America Alopecia Market, By Treatment, 2019-2031 (USD Billion)

59. South America Alopecia Market, By End-User, 2019-2031 (USD Billion)

60. Brazil Alopecia Market, By Disease Type, 2019-2031 (USD Billion)

61. Brazil Alopecia Market, By Treatment, 2019-2031 (USD Billion)

62. Brazil Alopecia Market, By End-User, 2019-2031 (USD Billion)

63. Middle East and Africa Alopecia Market, By Disease Type, 2019-2031 (USD Billion)

64. Middle East and Africa Alopecia Market, By Treatment, 2019-2031 (USD Billion)

65. Middle East and Africa Alopecia Market, By End-User, 2019-2031 (USD Billion)

66. UAE Alopecia Market, By Disease Type, 2019-2031 (USD Billion)

67. UAE Alopecia Market, By Treatment, 2019-2031 (USD Billion)

68. UAE Alopecia Market, By End-User, 2019-2031 (USD Billion)

69. South Africa Alopecia Market, By Disease Type, 2019-2031 (USD Billion)

70. South Africa Alopecia Market, By Treatment, 2019-2031 (USD Billion)

71. South Africa Alopecia Market, By End-User, 2019-2031 (USD Billion)

List of Figures 

1. Global Alopecia Market Segmentation

2. Global Alopecia Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Alopecia Market Attractiveness Analysis By Disease Type

9. Global Alopecia Market Attractiveness Analysis By Treatment

10. Global Alopecia Market Attractiveness Analysis By End-User

11. Global Alopecia Market Attractiveness Analysis By Region

12. Global Alopecia Market: Dynamics

13. Global Alopecia Market Share By Disease Type (2023 & 2031)

14. Global Alopecia Market Share By Treatment (2023 & 2031)

15. Global Alopecia Market Share By End-User (2023 & 2031)

16. Global Alopecia Market Share By Regions (2023 & 2031)

17. Global Alopecia Market Share By Company (2021)

This study forecasts global, regional, and country revenue from 2019 to 2031. Brainy Insights has segmented the global alopecia      market based on the below-mentioned segments:

Global Alopecia Market by Disease Type: 

  • Cicatricial Alopecia
  • Alopecia Areata
  • Alopecia Totalis
  • Traction Alopecia
  • Androgenetic Alopecia
  • Alopecia Universalis
  • Others

Global Alopecia Market by Treatment:

  • Devices
  • Pharmaceutical

Global Alopecia Market by End-User:

  • Dermatology Clinics
  • Homecare Settings

Global Alopecia Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date